About Alchimia Partners, LLC - Download Tony's C.V.


  • Education and Training
  • BS in Biology, Massachusetts Institute of Technology
  • MD-PhD, Albert Einstein College of Medicine
  • PhD topic – differentiation of liver progenitor cells
  • Internship and dermatology training at University of Pennsylvania
  • Elected to Phi Beta Kappa, Sigma Xi and Alpha Omega Alpha honor societies

  • Experience
  • Sell-side large-cap pharmaceuticals analyst at JP Morgan.
  • Biotechnology and Specialty Pharmaceuticals analyst and portfolio manager at Citigroup (long only), Sands Point Partners (long-short) and Pequot Capital (long-short)
  • President and CEO of EnzymeRx/Uricase Therapeutics.
    • Ran rodent GLP toxicity studies
    • Oversaw transfer and scale-up of E. coli-based manufacturing process
    • Developed and wrote two phase 1 clinical trial protocols
    • Successfully filed a pair of INDs
    • Ran two phase 1 studies
    • Drafted a patent application
    • Executed strategic sale of program after completion of phase 1
  • Have served as a Board member of Stemline, a private cancer stem cell company, and several not-for-profit institutions
  • Over 20 published articles in the medical and scientific literature
  • Expert witness in Alaska Pension Fund et al. versus Pharmacia et al.

  • Representative Prior Engagements
  • Advised a venture capital fund on a large potential investment in an oncology-focused startup being spun out of a pharmaceutical company.
  • Provided interim executive management services to a small company seeking a financing or partnership for a clinical stage asset.
  • Prepared material for a biotechnology investment fund preparing to sell a portfolio holding.
  • Wrote several analytical reports for hedge funds considering long or short positions in specific biotechnology companies.
  • Assisted three private biotechnology companies in preparation of investor materials, including slide presentations and executive summaries.
  • Held several investor meetings to discuss the developing therapeutic landscape in gout under the auspices of a broker-dealer.
  • Provided an expert opinion on behalf of the Defendant, and rebuttals of the Plaintiffs' experts, in a securities class action litigation against a pharmaceutical company.